Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025.

Saved in:
Bibliographic Details
Title: Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025.
Authors: Moulia DL, Link-Gelles R, Chu HY, Jamieson D, Brooks O, Meyer S, Weintraub ES, Shay DK, Prill MM, Thomas ES, Hutton D, Ortega-Sanchez IR, MacNeil A, McMorrow ML, Jones JM
Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2025 Aug 28; Vol. 74 (32), pp. 508-514. Date of Electronic Publication: 2025 Aug 28.
Publication Type: Journal Article; Practice Guideline
Journal Info: Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1545-861X
DOI:10.15585/mmwr.mm7432a3